These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 7285392)
1. Inhibition of monocyte complement receptor enhancement by low molecular weight material from human lung cancers. Glass EJ; Abell CA; Kay AB Clin Exp Immunol; 1981 Mar; 43(3):540-8. PubMed ID: 7285392 [TBL] [Abstract][Full Text] [Related]
2. Receptor associated defects of cultured monocytes in bronchial carcinoma. Lukacs K; Carroll MP; Hodson ME; Kay AB Clin Exp Immunol; 1984 May; 56(2):321-9. PubMed ID: 6733974 [TBL] [Abstract][Full Text] [Related]
3. Defective chemotactic factor-induced monocyte complement receptor enhancement in lung cancer. Carroll M; Lukacs K; Hodson M; Kay AB Clin Exp Immunol; 1983 Dec; 54(3):785-92. PubMed ID: 6228358 [TBL] [Abstract][Full Text] [Related]
4. Enhanced expression of human monocyte complement (C3b) receptors by chemoattractants. Glass EJ; Kay AB Clin Exp Immunol; 1980 Mar; 39(3):768-75. PubMed ID: 7379336 [TBL] [Abstract][Full Text] [Related]
5. The effect of complement in adherent immune complexes on Fc and C3 receptor expression in human monocytes. Arend WP; Massoni RJ Immunology; 1981 Dec; 44(4):717-25. PubMed ID: 7319557 [TBL] [Abstract][Full Text] [Related]
6. Complement receptors on Raji cells. The presence of a new type of C3 receptor. Okuda T; Tachibana T Immunology; 1980 Sep; 41(1):159-66. PubMed ID: 7429548 [TBL] [Abstract][Full Text] [Related]
7. Human macrophage function in cancer: systemic and local changes detected by an assay for Fc receptor expression. Rhodes J; Plowman P; Bishop M; Lipscomb D J Natl Cancer Inst; 1981 Mar; 66(3):423-9. PubMed ID: 6937700 [TBL] [Abstract][Full Text] [Related]
9. Trypan blue inhibition of complement receptor function on various cells. Harper BL; Fine DP; Guckian JC; Cavallo T Immunology; 1981 Jan; 42(1):61-6. PubMed ID: 7461725 [TBL] [Abstract][Full Text] [Related]
10. Functional discrimination by human monocytes between their C3b receptors and their recognition units for particulate activators of the alternative complement pathway. Czop JK; Austen KF J Immunol; 1980 Jul; 125(1):124-8. PubMed ID: 7381198 [TBL] [Abstract][Full Text] [Related]
11. Induction of TNF-alpha, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells. Niiya M; Niiya K; Kiguchi T; Shibakura M; Asaumi N; Shinagawa K; Ishimaru F; Kiura K; Ikeda K; Ueoka H; Tanimoto M Cancer Chemother Pharmacol; 2003 Nov; 52(5):391-8. PubMed ID: 12908082 [TBL] [Abstract][Full Text] [Related]
12. Receptors on guinea-pig erythrocytes specific for cell-bound fourth component of human complement (C4). Wilson AB; Prichard-Thomas S; Lachmann PJ; Coombs RR Immunology; 1980 Feb; 39(2):195-202. PubMed ID: 7380467 [TBL] [Abstract][Full Text] [Related]
13. Enhancement of monocyte complement component synthesis by antigen--antibody complexes. McPhaden A; Lappin D; Whaley K Immunology; 1981 Sep; 44(1):193-200. PubMed ID: 7275185 [TBL] [Abstract][Full Text] [Related]
14. Physicochemical characterization of C3b receptors isolated from human erythrocytes by immunoprecipitation. Gerdes J; Stein H Immunology; 1980 Dec; 41(4):929-36. PubMed ID: 7461716 [TBL] [Abstract][Full Text] [Related]
15. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis. Hepburn AL; Mason JC; Davies KA Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618 [TBL] [Abstract][Full Text] [Related]
16. Fc and C3b receptors on cultured retinoblastoma cells. Stein PC; Rand N; Char DH Invest Ophthalmol Vis Sci; 1981 Oct; 21(4):550-3. PubMed ID: 7287344 [TBL] [Abstract][Full Text] [Related]
17. Development of functional complement receptors during in vitro maturation of human monocytes into macrophages. Newman SL; Musson RA; Henson PM J Immunol; 1980 Nov; 125(5):2236-44. PubMed ID: 7430626 [TBL] [Abstract][Full Text] [Related]
18. A monocyte function test (complement receptor enhancement) to assess the extent of bronchial carcinoma. Carroll M; Smith MJ; Hodson ME; Kay AB Thorax; 1987 Jan; 42(1):53-8. PubMed ID: 3616973 [TBL] [Abstract][Full Text] [Related]
19. Differential expression of the C5a receptor and complement receptors 1 and 3 after LPS stimulation of neutrophils and monocytes. Furebring M; Håkansson L; Venge P; Sjölin J Scand J Immunol; 2004 Nov; 60(5):494-9. PubMed ID: 15541042 [TBL] [Abstract][Full Text] [Related]
20. Specific antibody-dependent phagocytosis of lipid vesicles by RAW264 macrophages results in the loss of cell surface Fc but not C3b receptor activity. Petty HR; Hafeman DG; McConnell HM J Immunol; 1980 Dec; 125(6):2391-6. PubMed ID: 7430632 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]